We have previously shown in human HNSCC cell lines that inhibition of MK2 with the MK2 inhibitor, PF-3644022, could reduce EMT gene expression, in vitro [30]. The gene discussed is MAPKAPK2; the disease is head and neck squamous cell carcinoma.